CAMP - NASDAQ

CAMP4 Therapeutics Corporation

CAMP·NASDAQ

$4.24

+1.7%

HealthcareBiotechnology

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$90.06M

EPS-2.6500

P/E Ratio-1.60

Earnings Date08/13/2026

camp

Selling, General and Administrative Expenses

Last Annual Value

17.36M

3-Year CAGR

19%

5-Year CAGR

-29%

10-Year CAGR

-10%

Adjust for Inflation

CAMP4 Therapeutics Corporation Competitors Analysis of Selling, General and Administrative Expenses

CAMP · NASDAQ

Company	Selling, General and Administrative Expenses	CAGR 3Y	CAGR 5Y	CAGR 10Y
CAMP4 Therapeutics Corporation NASDAQ:CAMP	17.36M	14.3%	-29.7%	-16.5%
Unicycive Therapeutics, Inc. NASDAQ:UNCY	20.40M	33.6%	47.7%	N/A
Cue Biopharma, Inc. NASDAQ:CUE	16.24M	-0.9%	-1.3%	23.5%
NRx Pharmaceuticals, Inc. NASDAQ:NRXP	13.06M	-2.8%	-29.5%	N/A
Artiva Biotherapeutics, Inc. NASDAQ:ARTV	20.27M	13.4%	9.5%	N/A
Precision BioSciences, Inc. NASDAQ:DTIL	32.24M	-6.2%	-4.1%	18.1%
Prelude Therapeutics Incorporated NASDAQ:PRLD	22.41M	-8.1%	-3.6%	N/A
Relmada Therapeutics, Inc. NASDAQ:RLMD	311.90K	-81.5%	-61.1%	-25.2%
Sutro Biopharma, Inc. NASDAQ:STRO	41.02M	-13.1%	-6.0%	10.7%
Outlook Therapeutics, Inc. NASDAQ:OTLK	39938.23B	11340.3%	1890.9%	323.4%
CEL-SCI Corporation AMEX:CVM	4.22M	-22.3%	-20.2%	-4.2%

CAMP4 Therapeutics Corporation Fair Value Envelope

CAMP · NASDAQ

Our analysis suggests that CAMP has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $4.24, this represents a potential HIDDEN relative to our calculated worth for CAMP4 Therapeutics Corporation.

HIDDEN

Intrinsic Value

Current Price: $4.24

Related Guides

Blog Categories

Continue your CAMP research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.